Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies

C. A. Köhler, T. H. Freitas, M. Maes, N. Q. de Andrade, C. S. Liu, B. S. Fernandes, B. Stubbs, M. Solmi, N. Veronese, N. Herrmann, C. L. Raison, B. J. Miller, K. L. Lanctôt, A. F. Carvalho

Research output: Contribution to journalArticle

212 Citations (Scopus)

Abstract

Objective: To conduct a systematic review and meta-analysis of studies that measured cytokine and chemokine levels in individuals with major depressive disorder (MDD) compared to healthy controls (HCs). Method: The PubMed/MEDLINE, EMBASE, and PsycINFO databases were searched up until May 30, 2016. Effect sizes were estimated with random-effects models. Result: Eighty-two studies comprising 3212 participants with MDD and 2798 HCs met inclusion criteria. Peripheral levels of interleukin-6 (IL-6), tumor necrosis factor (TNF)-alpha, IL-10, the soluble IL-2 receptor, C-C chemokine ligand 2, IL-13, IL-18, IL-12, the IL-1 receptor antagonist, and the soluble TNF receptor 2 were elevated in patients with MDD compared to HCs, whereas interferon-gamma levels were lower in MDD (Hedge's g = −0.477, P = 0.043). Levels of IL-1β, IL-2, IL-4, IL-8, the soluble IL-6 receptor (sIL-6R), IL-5, CCL-3, IL-17, and transforming growth factor-beta 1 were not significantly altered in individuals with MDD compared to HCs. Heterogeneity was large (I2: 51.6–97.7%), and sources of heterogeneity were explored (e.g., age, smoking status, and body mass index). Conclusion: Our results further characterize a cytokine/chemokine profile associated with MDD. Future studies are warranted to further elucidate sources of heterogeneity, as well as biosignature cytokines secreted by other immune cells.

Original languageEnglish (US)
Pages (from-to)373-387
Number of pages15
JournalActa Psychiatrica Scandinavica
Volume135
Issue number5
DOIs
StatePublished - May 1 2017

Fingerprint

Major Depressive Disorder
Chemokines
Meta-Analysis
Depression
Cytokines
Receptors, Tumor Necrosis Factor, Type II
Interleukin-6 Receptors
CC Chemokines
Interleukin-18
Interleukin-1 Receptors
Interleukin-13
Interleukin-17
Interleukin-2 Receptors
Interleukin-5
Interleukin-12
Interleukin-8
Interleukin-1
PubMed
MEDLINE
Interleukin-4

Keywords

  • chemokines
  • cytokines
  • depression
  • inflammation
  • meta-analysis

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., ... Carvalho, A. F. (2017). Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatrica Scandinavica, 135(5), 373-387. https://doi.org/10.1111/acps.12698

Peripheral cytokine and chemokine alterations in depression : a meta-analysis of 82 studies. / Köhler, C. A.; Freitas, T. H.; Maes, M.; de Andrade, N. Q.; Liu, C. S.; Fernandes, B. S.; Stubbs, B.; Solmi, M.; Veronese, N.; Herrmann, N.; Raison, C. L.; Miller, B. J.; Lanctôt, K. L.; Carvalho, A. F.

In: Acta Psychiatrica Scandinavica, Vol. 135, No. 5, 01.05.2017, p. 373-387.

Research output: Contribution to journalArticle

Köhler, CA, Freitas, TH, Maes, M, de Andrade, NQ, Liu, CS, Fernandes, BS, Stubbs, B, Solmi, M, Veronese, N, Herrmann, N, Raison, CL, Miller, BJ, Lanctôt, KL & Carvalho, AF 2017, 'Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies', Acta Psychiatrica Scandinavica, vol. 135, no. 5, pp. 373-387. https://doi.org/10.1111/acps.12698
Köhler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatrica Scandinavica. 2017 May 1;135(5):373-387. https://doi.org/10.1111/acps.12698
Köhler, C. A. ; Freitas, T. H. ; Maes, M. ; de Andrade, N. Q. ; Liu, C. S. ; Fernandes, B. S. ; Stubbs, B. ; Solmi, M. ; Veronese, N. ; Herrmann, N. ; Raison, C. L. ; Miller, B. J. ; Lanctôt, K. L. ; Carvalho, A. F. / Peripheral cytokine and chemokine alterations in depression : a meta-analysis of 82 studies. In: Acta Psychiatrica Scandinavica. 2017 ; Vol. 135, No. 5. pp. 373-387.
@article{b495022367b74751b0ac3997dc3720db,
title = "Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies",
abstract = "Objective: To conduct a systematic review and meta-analysis of studies that measured cytokine and chemokine levels in individuals with major depressive disorder (MDD) compared to healthy controls (HCs). Method: The PubMed/MEDLINE, EMBASE, and PsycINFO databases were searched up until May 30, 2016. Effect sizes were estimated with random-effects models. Result: Eighty-two studies comprising 3212 participants with MDD and 2798 HCs met inclusion criteria. Peripheral levels of interleukin-6 (IL-6), tumor necrosis factor (TNF)-alpha, IL-10, the soluble IL-2 receptor, C-C chemokine ligand 2, IL-13, IL-18, IL-12, the IL-1 receptor antagonist, and the soluble TNF receptor 2 were elevated in patients with MDD compared to HCs, whereas interferon-gamma levels were lower in MDD (Hedge's g = −0.477, P = 0.043). Levels of IL-1β, IL-2, IL-4, IL-8, the soluble IL-6 receptor (sIL-6R), IL-5, CCL-3, IL-17, and transforming growth factor-beta 1 were not significantly altered in individuals with MDD compared to HCs. Heterogeneity was large (I2: 51.6–97.7{\%}), and sources of heterogeneity were explored (e.g., age, smoking status, and body mass index). Conclusion: Our results further characterize a cytokine/chemokine profile associated with MDD. Future studies are warranted to further elucidate sources of heterogeneity, as well as biosignature cytokines secreted by other immune cells.",
keywords = "chemokines, cytokines, depression, inflammation, meta-analysis",
author = "K{\"o}hler, {C. A.} and Freitas, {T. H.} and M. Maes and {de Andrade}, {N. Q.} and Liu, {C. S.} and Fernandes, {B. S.} and B. Stubbs and M. Solmi and N. Veronese and N. Herrmann and Raison, {C. L.} and Miller, {B. J.} and Lanct{\^o}t, {K. L.} and Carvalho, {A. F.}",
year = "2017",
month = "5",
day = "1",
doi = "10.1111/acps.12698",
language = "English (US)",
volume = "135",
pages = "373--387",
journal = "Acta Psychiatrica Scandinavica",
issn = "0001-690X",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Peripheral cytokine and chemokine alterations in depression

T2 - a meta-analysis of 82 studies

AU - Köhler, C. A.

AU - Freitas, T. H.

AU - Maes, M.

AU - de Andrade, N. Q.

AU - Liu, C. S.

AU - Fernandes, B. S.

AU - Stubbs, B.

AU - Solmi, M.

AU - Veronese, N.

AU - Herrmann, N.

AU - Raison, C. L.

AU - Miller, B. J.

AU - Lanctôt, K. L.

AU - Carvalho, A. F.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Objective: To conduct a systematic review and meta-analysis of studies that measured cytokine and chemokine levels in individuals with major depressive disorder (MDD) compared to healthy controls (HCs). Method: The PubMed/MEDLINE, EMBASE, and PsycINFO databases were searched up until May 30, 2016. Effect sizes were estimated with random-effects models. Result: Eighty-two studies comprising 3212 participants with MDD and 2798 HCs met inclusion criteria. Peripheral levels of interleukin-6 (IL-6), tumor necrosis factor (TNF)-alpha, IL-10, the soluble IL-2 receptor, C-C chemokine ligand 2, IL-13, IL-18, IL-12, the IL-1 receptor antagonist, and the soluble TNF receptor 2 were elevated in patients with MDD compared to HCs, whereas interferon-gamma levels were lower in MDD (Hedge's g = −0.477, P = 0.043). Levels of IL-1β, IL-2, IL-4, IL-8, the soluble IL-6 receptor (sIL-6R), IL-5, CCL-3, IL-17, and transforming growth factor-beta 1 were not significantly altered in individuals with MDD compared to HCs. Heterogeneity was large (I2: 51.6–97.7%), and sources of heterogeneity were explored (e.g., age, smoking status, and body mass index). Conclusion: Our results further characterize a cytokine/chemokine profile associated with MDD. Future studies are warranted to further elucidate sources of heterogeneity, as well as biosignature cytokines secreted by other immune cells.

AB - Objective: To conduct a systematic review and meta-analysis of studies that measured cytokine and chemokine levels in individuals with major depressive disorder (MDD) compared to healthy controls (HCs). Method: The PubMed/MEDLINE, EMBASE, and PsycINFO databases were searched up until May 30, 2016. Effect sizes were estimated with random-effects models. Result: Eighty-two studies comprising 3212 participants with MDD and 2798 HCs met inclusion criteria. Peripheral levels of interleukin-6 (IL-6), tumor necrosis factor (TNF)-alpha, IL-10, the soluble IL-2 receptor, C-C chemokine ligand 2, IL-13, IL-18, IL-12, the IL-1 receptor antagonist, and the soluble TNF receptor 2 were elevated in patients with MDD compared to HCs, whereas interferon-gamma levels were lower in MDD (Hedge's g = −0.477, P = 0.043). Levels of IL-1β, IL-2, IL-4, IL-8, the soluble IL-6 receptor (sIL-6R), IL-5, CCL-3, IL-17, and transforming growth factor-beta 1 were not significantly altered in individuals with MDD compared to HCs. Heterogeneity was large (I2: 51.6–97.7%), and sources of heterogeneity were explored (e.g., age, smoking status, and body mass index). Conclusion: Our results further characterize a cytokine/chemokine profile associated with MDD. Future studies are warranted to further elucidate sources of heterogeneity, as well as biosignature cytokines secreted by other immune cells.

KW - chemokines

KW - cytokines

KW - depression

KW - inflammation

KW - meta-analysis

UR - http://www.scopus.com/inward/record.url?scp=85017002844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017002844&partnerID=8YFLogxK

U2 - 10.1111/acps.12698

DO - 10.1111/acps.12698

M3 - Article

C2 - 28122130

AN - SCOPUS:85017002844

VL - 135

SP - 373

EP - 387

JO - Acta Psychiatrica Scandinavica

JF - Acta Psychiatrica Scandinavica

SN - 0001-690X

IS - 5

ER -